This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Potentially resectable metastatic colorectal cance...
Clinical trial

Potentially resectable metastatic colorectal cancer with wild-type KRAS and BRAF: alternating chemotherapy plus cetuximab - A randomised phase II trial - Nordic 7.6

Read time: 1 mins
Last updated:3rd Jan 2012
Response rate (RR) estimate by the investigator
Category Value
Study start date 2012-01-03

View full details